Trump’s Pick for FDA Chief Has Drug and Biotech Industry Ties
President Trump’s pick for head of the FDA, Dr. Scott Gottlieb, has taken more than $400,000 from drug makers in the last few years alone, and Gottlieb has deep ties to the pharmaceutical industry. [1]
Gottlieb has testified multiple times on Capitol Hill concerning complex drug pricing issues, and is largely approved of by drug companies and pharmaceutical investors for FDA head. He’s on the boards of directors of several small drug and biotech companies, while also serving as an adviser to GlaxoSmithKline PLC. [2]
